Viewing Study NCT02971618


Ignite Creation Date: 2025-12-25 @ 4:32 AM
Ignite Modification Date: 2026-01-17 @ 10:09 AM
Study NCT ID: NCT02971618
Status: COMPLETED
Last Update Posted: 2019-08-06
First Post: 2016-11-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study With Dapagliflozin
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module